Drug Database
Back to search

United States· US:10702-017_7d67f785-a25f-1819-e053-2991aa0a11d3

Chlorphen-12

A chlorphenamine product containing chlorpheniramine maleate, registered in United States by KVK-Tech, Inc.. The same ATC class is registered in 7 of our 19 countries.

ATC R06AB04

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedChlorphen-12ATCR06AB04REGISTER NO.US:10702-017_7d67f785…PACKS LISTED8CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorpheniramine maleateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chlorphenamine is registered in 7 of 19 countries.

Countries holding a registration under ATC R06AB04 (chlorphenamine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose
Search chlorphenamine products by name

Chlorphenamine · ATC R06AB04

7 / 19 countries

  • Belgiumprice
  • Canada
  • Ireland
  • Japan
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CHLORPHENIRAMINE MALEATE
Manufacturer
KVK-Tech, Inc.
Country
United States (US)
ATC code
R06AB04
ATC class
Chlorphenamine
Defined daily dose
12 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 8

  • ndc11
    1070201701
    100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10702-017-01)
  • ndc11
    1070201706
    60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10702-017-06)
  • ndc11
    1070201724
    24 TABLET, FILM COATED, EXTENDED RELEASE in 1 CARTON (10702-017-24)
  • ndc11
    1070201754
    50 PACKAGE in 1 CARTON (10702-017-54) / 4 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (10702-017-04)
  • ndc11
    10702-017-01
  • ndc11
    10702-017-06
  • ndc11
    10702-017-24
  • ndc11
    10702-017-54

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

387 interactions on record for chlorphenamine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chlorphenamine against other medicinesHow interaction checks work

Chlorphenamine · interactions on record

387 records

  • 9 severe
  • 332 moderate
  • 2 minor
  • 44 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • Sodium oxybateN01AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chlorphenamine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorphenamine products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · 1 Year Plus Allergy Relief Antihistamine, Allergy Relief
  • Greece · Drastino(N), Istamex
  • Ireland · Chlorphenamine Evolan Pharma, Piriton Allergy
  • Italy · Trimeton
  • Romania · Clorfeniramin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c84fc12f-431c-467f-8f99-6c3d91e5afa5
GET /v1/drugs/c84fc12f-431c-467f-8f99-6c3d91e5afa5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "12",
  "substance": "CHLORPHENIRAMINE MALEATE",
  "productndc": "10702-017",
  "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA040829",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about chlorphenamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console